Valuation: Danaher Corporation

Market Cap 134B 117B 108B 101B 190B 12,614B 193B 1,298B 503B 6,218B 502B 491B 21,608B P/E 2026 *
30.1x
P/E 2027 * 24.8x
Enterprise Value 134B 117B 108B 101B 190B 12,614B 193B 1,298B 503B 6,218B 502B 491B 21,608B EV / Sales 2026 *
5.15x
EV / Sales 2027 * 4.74x
Free-Float
71.13%
Yield 2026 *
0.76%
Yield 2027 * 0.81%
1 day+2.80%
1 week+9.87%
Current month+6.56%
1 month+12.64%
3 months+4.01%
6 months-15.48%
Current year-14.97%
1 week 175
Extreme 175
197.57
1 month 169.88
Extreme 169.88
197.57
Current year 160.93
Extreme 160.93
242.8
1 year 160.93
Extreme 160.93
242.8
3 years 160.93
Extreme 160.93
281.7
5 years 160.93
Extreme 160.93
333.96
10 years 75.71
Extreme 75.71
333.96
Manager TitleAgeSince
Chief Executive Officer 62 01/09/2020
Director of Finance/CFO - 28/02/2026
Chief Tech/Sci/R&D Officer - 25/08/2025
Director TitleAgeSince
Director/Board Member 74 01/07/1999
Chairman 74 01/01/1984
Director/Board Member 69 01/01/1984
Date Insider Type Main position Quantity % Market Cap.
05-15Free

Director

2,379 0.0003%
05-15Free

Director

2,379 0.0003%
05-15Free

Director

2,379 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+2.80%+9.87%-3.15%-18.17% 134B
+3.41%+9.86%+24.30%-2.22% 183B
-0.17%-0.94%-22.75%+23.92% 142B
-0.55%-2.04%-57.46%-17.07% 66.08B
+0.76%+3.41%+17.36%+0.94% 51.63B
+0.50%-0.09%-26.76%-31.94% 43.38B
+4.43%+8.37%+16.08%+16.33% 37.18B
+2.16%+6.30%+7.95%+45.47% 36.25B
+0.26%+5.94%-10.31%-16.13% 29.51B
+1.99%+6.34%-22.22%-6.48% 28.38B
Average +1.52%+0.31%-7.70%-0.53% 75.13B
Weighted average by Cap. +1.72%-0.37%-4.43%-0.40%

Financials

2026 *2027 *
Net sales 25.96B 22.81B 21.01B 19.65B 36.85B 2,450B 37.53B 252B 97.65B 1,208B 97.5B 95.36B 4,197B 28.23B 24.79B 22.84B 21.36B 40.06B 2,663B 40.8B 274B 106B 1,313B 106B 104B 4,563B
Net income 4.42B 3.88B 3.57B 3.34B 6.27B 417B 6.38B 42.89B 16.61B 205B 16.59B 16.22B 714B 5.35B 4.7B 4.33B 4.05B 7.59B 505B 7.73B 51.93B 20.11B 249B 20.08B 19.64B 864B
Net Debt - -
Logo Danaher Corporation
Danaher Corporation is an industrial and technologic group organized around three families of products: - diagnostic equipment (40.5% of net sales); - life sciences equipment (29.8%); - biotechnology equipment (29.7%): ranging from basic biological research to the development and manufacturing of vaccines, biological drugs, cell and gene therapies, and new technologies such as mRNA. Net sales are distributed geographically as follows: the United States (40.6%), China (10.7%) and other (48.7%).
Employees
59,000
Date Price Change Volume
25/06/26 $194.74 +3.11% 2,797,303
24/06/26 $188.87 +5.53% 5,646,978
23/06/26 $178.97 +0.44% 4,149,960
22/06/26 $178.19 +0.58% 3,691,892
18/06/26 $177.17 -0.33% 7,258,518
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
26
Last Close Price
188.87USD
Average target price
242.35USD
Spread / Average Target
+28.31%

Quarterly revenue - Rate of surprise